EDGEMOND JAMES sold UTHR
May 21, 2026 · Form 4 insider transaction
EDGEMOND JAMES sold 40 shares of United Therapeutics Corporation at $557.85 per share, a transaction worth $22.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
40
Price
$557.85
Total value
$22.3K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 21, 2026
Filing dateMay 22, 2026
Shares owned after28,836
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.